Journal of Substance Abuse Treatment
Volume 35, Issue 1 , Pages 1-12 , July 2008

Longitudinal trends in hospital admissions with co-occurring alcohol/drug diagnoses, 1994–2002

  • Patricia B. Santora, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Meyer Building 3-142, Baltimore, MD 21287, USA. Tel.: +1 410 955 6871; fax: +1 410 955 6901.
    • ,
  • Heidi E. Hutton, Ph.D.

Received 19 December 2006 ,Revised 13 July 2007 ,Accepted 8 August 2007.

References 

  1. Adelman PK. Mental and substance abuse disorders among Medicaid recipients: Prevalence estimates from two national surveys. Administration and Policy in Mental Health. 2003;31:111–129
  2. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: A randomized controlled trial. Journal of the American Medical Association. 2006;295:2003–2017
  3. Baldwin WA, Rosenfeld BA, Breslow MJ, Buchman TG, Deutschman CS, Moore RD. Substance abuse-related admissions to adult intensive care. Chest. 1993;103:21–25
  4. Braden BR, Cowan CA, Lazenby HC, et al. National health expenditures, 1997. Health Care Financing Review. 1998;20:83–126
  5. Bradley CJ, Zarkin GA. Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse. Health Services Research. 1996;31:387–408
  6. Buck JA, Teich JL, Miller K. Use of mental health and substance abuse services among high-cost Medicaid enrollees. Administration and Policy in Mental Health. 2003;31:3–14
  7. Buckley PF, Brown ES. Prevalence and consequences in diagnosis. Journal of Clinical Psychiatry. 2006;67:e01
  8. Burke KC, Meek WJ, Krych R, Nisbet R, Burke JD. Medical services use by patients before and after detoxification from benzodiazepine dependence. Psychiatric Services. 1995;46:157–160
  9. Centers for Disease Control and Prevention . Trends in aging—United States and worldwide. Morbidity and Mortality Weekly Report. 2003;52:101–106
  10. Centers for Disease Control and Prevention . The burden of chronic diseases and their risk factors: National and state perspectives 2004. Atlanta: U.S. Department of Health and Human Services; 2004;
  11. Chou SP, Grant BF, Dawson DA. Medical consequences of alcohol consumption—United States, 1992. Alcoholism, Clinical and Experimental Research. 1996;20:1423–1429
  12. Coffey RM, Mark T, King E, Harwood H, McKusick D, Genuardi J, et al. National estimates of expenditures for substance abuse treatment, 1997. SAMHSA Publication No. SMA-01-3511 Rockville, MD: Center for Substance Abuse Treatment and Center for Mental Health Services, Substance Abuse and Mental Health Services Administration; 2001, February;
  13. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2007;64:566–576
  14. Elixhauser A, Russo CA. Conditions related to uninsured hospitalizations, 2003. Statistical Brief #8. Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2006, May;www.hcup-us.ahrq.gov/reports/statbriefs/sb8.jsp
  15. Fox K, Merrill JC, Chang H-H, Califano JA. Estimating the costs of substance abuse to the medicaid hospital care program. American Journal of Public Health. 1995;85:48–54
  16. French MT, Drummond M. A research agenda for economic evaluation of substance abuse services. Journal of Substance Abuse Treatment. 2005;29:125–137
  17. French MT, Homer JF, Nielsen AL. Does America spend enough on addiction treatment? Results from public opinion surveys. Journal of Substance Abuse Treatment. 2006;31:245–254
  18. French MT, McGeary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the costs of medical care. Social Science & Medicine. 2000;50:1703–1713
  19. Gentilello LM, Samuels PN, Henningfield JE, Santora PB. Alcohol screening and intervention in trauma centers: Confidentiality concerns and legal considerations. Journal of Trauma. 2005;59:1250–1255
  20. Gerson LW, Boex J, Hua K, Liebelt RA, Zumbar WR, Bush D, et al. Medical care use by treated and untreated substance abusing Medicaid patients. Journal of Substance Abuse Treatment. 2001;20:115–120
  21. Goldman HH, Frank RG, Burnam MA, et al. Behavioral health insurance parity for federal employees. New England Journal of Medicine. 2006;354:1378–1386
  22. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2004;61:807–816
  23. Greenfield SF, Azzone V, Huskamp H, Cuffel B, Croghan T, Goldman W, et al. Treatment for substance use disorders in a privately insured population under managed care: Costs and services use. Journal of Substance Abuse Treatment. 2004;27:265–275
  24. Harwood H. Updating estimates of the economic costs of alcohol abuse in the United States: Estimates, update methods, and data. Report prepared by The Lewin Group for the National Institute on Alcohol Abuse and Alcoholism. Based on estimates, analyses, and data reported. In:  Harwood H,  Fountain D,  Livermore G editor. The economic costs of alcohol and drug abuse in the United States 1992. Report prepared for the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Department of Health and Human Services, NIH Publication No. 98-4327. Rockville, MD: National Institutes of Health; 1998;p. 307–330
  25. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2007;64:830–842
  26. Hoff RA, Rosenheck RA. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Medical Care. 1998;36:835–843
  27. Holder HD. Cost benefits of substance abuse treatment: An overview of results from alcohol and drug abuse. Journal of Mental Health Policy and Economics. 1998;1:23–29
  28. Holder HD, Blose JO. Alcoholism treatment and total health care utilization and costs. A four-year longitudinal analysis of federal employees. Journal of the American Medical Association. 1986;256:1456–1460
  29. Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol. 1992;53:293–302
  30. Institute of Medicine of the National Academies . Improving the quality of health care for mental and substance-use conditions. Washington, DC: National Academies Press; 2006;
  31. John U, Rumpf H-J, Hapke U. Estimating prevalence of alcohol abuse and dependence in one general hospital: An approach to reduce sample selection bias. Alcohol and Alcohol. 1999;34:786–794
  32. Lange DE, Schacter B. Prevalence of alcohol related admissions to general medical units. International Journal of Psychiatry. 1989;19:371–384
  33. Lange, W. R., White, N., & Robinson, N. (1992). Medical complications of substance abuse. Postgrad Med, 92, 205–208, 211–214.
  34. Marik P, Mohedin B. Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol and Alcohol. 1996;31:393–396
  35. Mark TL, Buck JA, Dilonardo JD, Coffey RM, Chalk M. Medicaid expenditures on behavioral health care. Psychiatric Services. 2003;54:188–194
  36. Mark TL, Coffey RM. What drove private health insurance spending on mental health and substance abuse care, 1992–1999?. Health Affairs (Millwood). 2003;22:165–172
  37. Mark TL, Coffey RM, King E, et al. Spending on mental health and substance abuse treatment, 1987–1997. Health Affairs (Millwood). 2000;19:108–120
  38. Mark TL, Coffey RM, McKusick DR, et al. National estimates of expenditures for mental health services and substance abuse treatment, 1991–2001. SAMHSA Publication No. SMA 05-3999. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005;
  39. Mark TL, Coffey RM, Vandivort-Warren R, Harwood HJ, King EC. U.S. spending for mental health and substance abuse treatment, 1991–2001. Health Affairs (Millwood). 2005, Jan–Jun;[Suppl Web Exclusives: W5-133–W5-142]
  40. Marwick C. Physician leadership on national drug policy finds addiction treatment works. Journal of the American Medical Association. 1998;279:1149–1150
  41. Maryland Department of Health and Mental Hygiene . Trends and patterns in Maryland alcohol and drug abuse treatment. Catonsville, MD: Maryland Alcohol and Drug Abuse Administration; 2001;
  42. McLellan AT, Carise D, Kleber H. Can the national addiction treatment infrastructure support the public's demand for quality care?. Journal of Substance Abuse Treatment. 2003;25:117–121
  43. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284:1689–1695
  44. Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO. Comparison with matched controls. Archives of Internal Medicine. 2003;163:2511–2517
  45. Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Academic Medicine. 2001;7:410–418
  46. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. Journal of the American Medical Association. 2004;291:1238–1245
  47. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM. Prevalence, detection, and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association. 1989;261:403–407
  48. Muller A. Alcohol consumption and community hospital admissions in the United States: A dynamic regression analysis, 1950–1992. Addiction. 1996;91:231–242
  49. National Institute on Drug Abuse . Epidemiologic trends in drug abuse: Advance report. http://www.drugabuse.gov/PDF/CEWG/AdvReport606.pdf2006, June;
  50. O'Brien CP, Volkow N, Li T-K. What's in a word? Addiction versus dependence in DSM-IV. American Journal of Psychiatry. 2006;163:764–765
  51. Office of National Drug Control Policy . The economic costs of drug abuse in the United States, 1992–2002. Washington, DC: Executive Office of the President; 2004;(Publication No. 207303)
  52. Office of National Drug Control Policy . Profile of drug indicators, State of Maryland. Drug Policy Information Clearinghouse. http://www.whitehousedrugpolicy.gov/statelocal/md/index.html2006, July;
  53. Orford J, Somers M, Daniels V, Kirby B. Drinking amongst medical patients: Levels of risk and models of change. British Journal of Addiction. 1992;87:1691–1702
  54. O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: Medical therapies, complications, and overall treatment outcomes. Journal of General Internal Medicine. 2006;21:570–576
  55. Parthasarathy S, Weisner CM. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug and Alcohol Dependence. 2005;80:231–240
  56. Piette JD, Barnett PG, Moos RH. First-time admissions with alcohol-related medical problems: A 10-year follow-up of a national sample of alcoholic patients. Journal of Studies on Alcohol. 1998;59:89–96
  57. Pollini RA, O'Toole TP, Ford D, Bigelow G. Does this patient really want treatment? Factors associated with baseline and evolving readiness for change among hospitalized substance using adults interested in treatment. Addictive Behaviors. 2006;31:1904–1918
  58. Rice DP. Cost of illness studies: What is good about them?. Injury Prevention. 2000;6:177–178
  59. Rosenbaum S. Medicaid. New England Journal of Medicine. 2002;346:635–640
  60. Russo CA, Elixhauser A. Hospitalizations for alcohol abuse disorders, 2003. Statistical Brief #4. Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2006, June;www.hcup-us.ahrq.gov/reports/statbriefs/sb4.jsp
  61. Schmidt LA, Weisner CM. Private insurance and the utilization of chemical dependency treatment. Journal of Substance Abuse Treatment. 2005;28:67–76
  62. Schoenbaum M, Zhang W, Sturm R. Costs and utilization of substance abuse care in a privately insured population under managed care. Psychiatric Services. 1998;49:1573–1578
  63. Smothers BA, Yahr HT, Ruhl CE. Detection of alcohol use disorders in general hospital admissions in the United States. Archives of Internal Medicine. 2004;164:749–756
  64. Smothers BA, Yahr HT, Sinclair MD. Prevalence of current DSM-IV alcohol use disorders in short-stay, general hospital admissions, United States, 1994. Archives of Internal Medicine. 2003;163:713–719
  65. Stein MD. Injected-drug use: Complications and costs in the care of hospitalized HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes. 1994;7:469–473
  66. Stein MD. Medical consequences of substance abuse. Psychiatric Clinics of North America. 1999, Jun;22:351–370
  67. Stein MD, O'Sullivan PS, Ellis P, Perrin H, Wartenberg A. Utilization of medical services by drug abusers in detoxification. Journal of Substance Abuse. 1993;5:187–193
  68. Stuart ME, Weinrich M. Beyond managing Medicaid costs: Restructuring care. Milbank Quarterly. 1998;76:251–280
  69. Taylor CL, Kilbane P, Passmore N, Davies R. Prospective study of alcohol-related admissions in an inner city hospital. Lancet. 1986;2:265–268
  70. U.S. Drug Enforcement Administration . DEA briefs and background, drugs and drug abuse, state factsheets, Maryland. http://www.dea.gov/pubs/states/maryland.html2007;
  71. Volkow ND, Li T-K. Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences. Pharmacology & Therapeutics. 2005;108:3–17
  72. Wallerstedt S, Denison H, Sandstrom J, Westin J. The prevalence of alcoholism and its relation to cause of hospitalization and long-term mortality in male somatic inpatients. Journal of Internal Medicine. 1995;237:339–344
  73. Walter LJ, Ackerson L, Allen S. Medicaid chemical dependency patients in a commercial health plan: Do high medical costs come down over time?. Journal of Behavioral Health Services & Research. 2005;32:253–263
  74. Zuvekas SH. Trends in mental health services use and spending, 1987–1996. Health Affairs (Millwood). 2001;20:214–224

PII: S0740-5472(07)00237-1

doi: 10.1016/j.jsat.2007.08.002

Journal of Substance Abuse Treatment
Volume 35, Issue 1 , Pages 1-12 , July 2008

Article Tools

* Image Usage & Resolution